ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 24 analysts with an average price target of $24.52. This is a potential upside of $7.44 (43.56%) from yesterday's end of day stock price of $17.08.

ACADIA Pharmaceuticals's activity chart (see below) currently has 241 price targets and 241 ratings on display. The stock rating distribution of ACAD is 36.08% HOLD, 62.89% BUY and 1.03% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.67% with an average time for these price targets to be met of 222.62 days.

Highest price target for ACAD is $42, Lowest price target is $25, average price target is $24.52.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 25-Mar-2024. First documented stock forecast 06-May-2013.

Currently out of the existing stock ratings of ACAD, 35 are a HOLD (36.08%), 61 are a BUY (62.89%), 1 are a SELL (1.03%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

25

$7.2 (40.45%)

29

24 days ago

5/8 (62.5%)

$7.16 (40.13%)

26

Buy

30

$12.2 (68.54%)

40

1 months 5 days ago

16/19 (84.21%)

$10.44 (53.37%)

184

Buy

39

$21.2 (119.10%)

40

1 months 21 days ago

6/10 (60%)

$15.25 (64.21%)

94

Buy

33

$15.2 (85.39%)

33

1 months 21 days ago

8/19 (42.11%)

$9.25 (38.95%)

119

Buy

36

$18.2 (102.25%)

1 months 21 days ago

0/1 (0%)

$12.25 (51.58%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 222.62 days on average for the stock forecasts to be realized with a an average price target met ratio 70.67

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov has 4 price targets and 3 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $42.2

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$5.8

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?